Burke William P. Mr. 4

What Happened

• William P. Burke, a director of Axogen, had restricted stock units (RSUs) vest on June 19, 2026, resulting in the acquisition of 28,300 shares of Axogen common stock. The filing shows two entries of 14,150 shares each (total 28,300). The reported acquisition price is $0.00, meaning no cash was paid on vesting.

Key Details

• Transaction date: June 19, 2026. Filing date: June 23, 2026 (filed within SEC Form 4 timing requirements).
• Price per share reported: $0.00; Total cash paid: $0.
• Shares acquired: 14,150 + 14,150 = 28,300 shares via conversion/vesting of RSUs (transaction code M = exercise/conversion of derivative).
• Shares owned after the transaction: Not specified in this Form 4.
• Footnotes: F1–F3 note these were RSUs that vested on June 19, 2026; each RSU converts to one share; this was an annual director equity grant valued at $150,000 at grant and vested on its one-year anniversary.

Context

• This was vesting/conversion of director RSUs (an award), not an open-market purchase or sale. No immediate sale was reported here, and no cash was exchanged on vesting.
• Vesting of grants to non-employee directors is common compensation and does not, by itself, indicate the director bought or sold shares in the market.